# Antigenics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/antigenics

- Industry: Biotechnology
- Headquarters: Lexington, US
- Website: www.agenusbio.com
- Total disclosed funding: $28M
- Latest round: Series D (Jan 11, 1999)
- Investors on record: 3

## About

Based in Lexington, US, Antigenics is a biotechnology company focused on technology and products to treat cancers, infectious diseases, and autoimmune disorders.

## Funding rounds

- Series D, Jan 11, 1999, $28M — Deutsche Bank, Elan Corporation, Oracle Capital Partners

## Investors

- Deutsche Bank — Series D
- Elan Corporation — Series D
- Oracle Capital Partners (https://capitalatlas.ai/funds/oracle-capital-partners) — Series D